Ratifi English Iniciar sesión
Ratifi

Proyectos federales de Congress.gov. Proyectos estatales de Open States.

SB 939Sesión 2025

Qué cambió entre versiones

13 párrafos cambiaron+136 palabras agregadas−118 eliminadas

El texto resaltado se agregó en la versión más reciente. El texto tachado se eliminó.

SB939 SFAH TakuboHHR AM #1 3-29

Dellinger 7965

CR 3338

SenatorThe TakuboCommittee on Health and Human Resources moved to amend the bill on page 1, section 4a, line 1, by striking outsubsection the(a) wordsin “asits a patient to an office-based medication assisted treatment”entirety and inserting ina lieunew thereofsubsection inserting(a) the words “to aread drug”;as follows:

On page 1, section 4a, by striking out all of subsection (c) and inserting in lieu thereof a new subsection (c), to read as follows:

(c) For the next year, the patient shall undergo a direct observation, qualitative or quantitative test every 45 days while in treatment.;

“(a) Upon patient admission to a medication-assisted treatment program, the provider shall conduct a clinically appropriate drug test, which may include direct observation, if the provider determines the patient is at high risk.”

And,

On page 1, line 3, by striking, “After this time and continuing for six weeks,” and inserting in lieu thereof, “At minimum,”

And,

On page 1, sectionline 4a3, by striking outthe allword, of subsection (d)“quantitative” and inserting in lieu thereof athe new subsection (d)word, to read as follows:“qualitative”

(d) After the first year of treatment, the patient shall undergo a direct observation, qualitative or quantitative test every six months thereafter until discharge from the program.;

And,

On page 1, lines 9 and 10 by striking, “the patient must be willing to produce a direct observation qualitative or quantitative test upon the provider request.” and inserting in lieu thereof, “the patient shall comply with a physician ordered direct observation qualitative or quantitative test.”

Adopted

Rejected

Volver al texto completo